These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28898512)

  • 21. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. To Vaccinate or Not: The Relative Impact of Attitudes toward Autism Spectrum Disorders and the Ability to Interpret Scientific Information on Vaccination Decisions.
    Thorsteinsson EB; Draper A; Lykins AD
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32276348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specialist vaccination advice and pockets of resistance to MMR vaccination: lessons from an outbreak of measles.
    Morgan OW; Meltzer M; Muir D; Hogan H; Seng C; Hill J; Beckford J
    Commun Dis Public Health; 2003 Dec; 6(4):330-3. PubMed ID: 15067861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals.
    Petrovic M; Roberts R; Ramsay M
    BMJ; 2001 Jan; 322(7278):82-85. PubMed ID: 11154622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethnicity as a correlate of the uptake of the first dose of mumps, measles and rubella vaccine.
    Mixer RE; Jamrozik K; Newsom D
    J Epidemiol Community Health; 2007 Sep; 61(9):797-801. PubMed ID: 17699534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of heterogeneity in uptake of the measles, mumps, and rubella vaccine on the potential for outbreaks of measles: a modelling study.
    Glasser JW; Feng Z; Omer SB; Smith PJ; Rodewald LE
    Lancet Infect Dis; 2016 May; 16(5):599-605. PubMed ID: 26852723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys.
    Ramsay ME; Yarwood J; Lewis D; Campbell H; White JM
    Br J Gen Pract; 2002 Nov; 52(484):912-6. PubMed ID: 12434960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel measles outbreak control strategy in the Netherlands in 2013-2014 using a national electronic immunization register: A study of early MMR uptake and its determinants.
    Nic Lochlainn LM; Woudenberg T; van Lier A; Zonnenberg I; Philippi M; de Melker HE; Hahné SJM
    Vaccine; 2017 Oct; 35(43):5828-5834. PubMed ID: 28923422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. U.K. parents' decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis.
    Brown KF; Long SJ; Ramsay M; Hudson MJ; Green J; Vincent CA; Kroll JS; Fraser G; Sevdalis N
    Vaccine; 2012 Feb; 30(10):1855-64. PubMed ID: 22230590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MMR vaccination: answers to some parents' questions.
    Moreton J
    J Fam Health Care; 2002; 12(6):151-3. PubMed ID: 12630143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doctors' attitudes and MMR-vaccination.
    Trier H
    Scand J Prim Health Care; 1991 Mar; 9(1):29-33. PubMed ID: 2041925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age.
    Yadav S; Thukral R; Chakarvarti A
    Indian J Med Res; 2003 Nov; 118():183-6. PubMed ID: 14723482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the relative importance of MMR vaccine concerns differ by degree of parental vaccine hesitancy?: An exploratory study.
    Gowda C; Schaffer SE; Kopec K; Markel A; Dempsey AF
    Hum Vaccin Immunother; 2013 Feb; 9(2):430-6. PubMed ID: 23032161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles, mumps, and rubella vaccine coverage in 2 year old children in East Lancashire--better than it looks.
    Clark A; Marshall R
    Commun Dis Public Health; 1999 Jan; 2(1):50-3. PubMed ID: 10462897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with poor adherence to MMR vaccination in parents who follow vaccination schedule.
    Restivo V; Napoli G; Marsala MG; Bonanno V; Sciuto V; Amodio E; Calamusa G; Vitale F; Firenze A
    Hum Vaccin Immunother; 2015; 11(1):140-5. PubMed ID: 25483527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timeliness of MMR vaccination and barriers to vaccination in preschool children.
    Jeong YW; Park BH; Kim KH; Han YR; Go UY; Choi WS; Kong KA; Park H
    Epidemiol Infect; 2011 Feb; 139(2):247-56. PubMed ID: 20412613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination coverage for measles, mumps and rubella in anthroposophical schools in Gelderland, The Netherlands.
    Klomp JH; van Lier A; Ruijs WL
    Eur J Public Health; 2015 Jun; 25(3):501-5. PubMed ID: 25406448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.